Save time and get answers to complex questions with AI chat
How to apply for vascepa's patient assistance?Bortezomib market france?Antiox mebendazole price?Pramlintide fda approval date?Mebendazole ingredients?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) was developed by the U.S. biotechnology company Merck (known as Merck Sharp & Dohme, a division of Merck & Co.). It is an antibody drug that came from Merck’s internal research and development program for immuno-oncology therapies.
Other Questions About Keytruda :